This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease (CD). The purpose of this study is to compare different doses of the investigational medication with a placebo to assess their effectiveness in managing CD symptoms.Participants in this study will undergo …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. The purpose of this study is to evaluate how different doses of the investigational medication affect clinical remission in participants with this condition.Participants will be randomly assigned to receive either the investigational medication …
This study investigates the safety and efficacy of an investigational antibody in protecting against Respiratory Syncytial Virus (RSV) in young children. This study involves neonates and infants aged 0 to 12 months, as well as children up to 24 months of age who are vulnerable to severe RSV disease.Participants will …
This study investigates the effects of an investigational medication on preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Participants in this study will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving standard care therapy.Participants …
This study investigates an investigational medication for adults with moderate to severe ulcerative colitis (UC). The purpose of this study is to evaluate the effectiveness and safety of the investigational medication compared to a placebo. Participants will be divided into four study arms, with three different doses of the investigational …
This study investigates the long-term safety and effects of an investigational medication in adults with asthma. The purpose of this study is to evaluate how safe and effective the investigational medication is for adults who have completed previous related studies.Participants in the study will continue their treatment with the investigational …
This study investigates the long-term safety and tolerability of an investigational medication in adults with different forms of multiple sclerosis, including relapsing MS (RMS), primary progressive MS (PPMS), and non-relapsing secondary progressive MS (NRSPMS).Participants in this study will continue to receive the investigational medication in an open-label format, meaning both …
This study investigates the effects of an investigational medication compared to an existing treatment in adults with relapsing forms of multiple sclerosis (RMS). The study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 years, using the investigational medication and comparing it to a daily …
This study investigates the long-term safety and efficacy of an investigational subcutaneous treatment for individuals aged 12 and older with moderate to severe atopic dermatitis (AD). The study aims to understand how the treatment works over an extended period, focusing on participants who have not responded well to other treatments.Participants …
This study investigates the clinical outcomes of patients with Gaucher disease. The study is observational, meaning it collects data from patients receiving routine care without altering their treatment. It aims to enhance understanding of the disease's variability, progression, and natural history to aid in better therapeutic interventions.Participants will undergo clinical …
